secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evofem Biosciences, Inc. (EVFM)
CIK:        0001618835
Form:       8-K
Filed at:   2023-07-10T23:59:59+00:00
Accession:  0001493152-23-024134
Event type: debt
Sentiment:  negative
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evofem raises $965k net via $1.5M convertible note and warrant offering
-----------------------------------------------------------------------

- Issued $1.5M principal of senior subordinated convertible notes with 8% interest (12% default); convertible at $1.25/share.
- Investors paid ~$650 per $1,000 principal (65% of face); net proceeds ~$965k after expenses.
- Warrants to purchase 1.2M shares at $1.25/share, exercisable for 5 years with cashless exercise and price adjustment.
- Notes mature March 6, 2026; change of control redemption at 125% premium; beneficial ownership capped at 4.99%.
- Registration rights agreement requires S-1 filing within 90 days; 2% monthly penalty for filing/effectiveness failure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1618835/000149315223024134/0001493152-23-024134-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1618835/000149315223024134/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-024134

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer